Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

522-526


Authors Details

Teena Agrawal, Mahesh Agarwal*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1029

PDF Downloaded: 912


Teleophthalmology and its impact- An eye disease pattern analysis in central India’s hot spot during COVID-19 pandemic


Original Article

Author Details : Teena Agrawal, Mahesh Agarwal*

Volume : 6, Issue : 4, Year : 2020

Article Page : 522-526

https://doi.org/10.18231/j.ijceo.2020.111



Suggest article by email

Get Permission

Abstract

Background: COVID-19 pandemic has put all of us in astonishment and concern about its management and survival of human being since there is a great risk of human to human transmission. Teleophthalmology can play a great role to overcome this situation. Earlier teleophthalmology was mainly limited to diagnoistic reachout camps for diabetic eye disease mainly without treatment benefit to the patient. Now with advancement in media technology and availability of good quality smart phones, it is possible to extend scope of teleophthalmlogy for the treatment of superficial ailments of an eye. Our aim of the study was to
analyse the eye disease pattern and impact of teleophthalmology on its management in one of the hot centre of India, i.e. Indore, during pandemic period.
Materials and Methods: This study is a retrospective, interventional data analysis of patients seen in one month of Lockdown in India, from 26th March to 25th April 2020. All the patients were given teleconsultation with the help of voice calls and still pictures; video call was used wherever it was feasible.
In our study, we have divided patients in two groups, first is Tele OSD (Tele Ocular Surface Disorders) where diagnosis on 2D image or video was possible and second group were OED (Other Eye Disease) where in-person consultation was required before making diagnosis or offering treatment.
Results: We have done analysis of total 119 patients records who made a call for eye problems between 26th March2020 to 25th April 2020. Out of 119 patients, 107 patients (89.91%) were in Tele OSD and 12 patients (10.08%) were in OED group. Telemedicine was prescribed in 103 patients (103/107, of tele OSD group- 96.26%), of which 102 patients (95.32%) showed marked improvement or are cured on followup.
Among the Tele OSD group who received the treatment (103 patients), 79 patients (76.99%) were of conjunctivitis, varying from infectious to allergic origin who responded very well to treatment offered.
Conclusion: COVID-19 pandemic has changed the understanding of medical science. Previously telemedicine (more precisely teleophthalmology) used to be a tool for outreach patient diagnosis mainly in rural or suburb area, but now with the advancement of digital media and easy availability of smart phones, it can also be used in the management of common eye diseases, even in urban population.

Keywords: Covid 19, Tele ophthalmology, Tele-OSD, Tele consultation, Telemedicine.


How to cite : Agrawal T , Agarwal M , Teleophthalmology and its impact- An eye disease pattern analysis in central India’s hot spot during COVID-19 pandemic. Indian J Clin Exp Ophthalmol 2020;6(4):522-526

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.